Related references
Note: Only part of the references are listed.Expression and production of human interleukin-7 in insect cells using baculovirus expression vector system (BEVS)
Maryam Mirzaei et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2008)
Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix (TM)] - A review of its use as an active immunization against influenza A subtype H5N1 virus
Natalie J. Carter et al.
BIODRUGS (2008)
WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine
Fang He et al.
BMC MICROBIOLOGY (2008)
Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue
E. Fonfria et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Influenza vaccines and vaccination strategies in birds
Thierry van den Berg et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2008)
Emerging vaccines for influenza
Pritish K. Tosh et al.
EXPERT OPINION ON EMERGING DRUGS (2008)
Pandemic H5N1 influenza vaccine development: an update
Hana M. El Sahlyt et al.
EXPERT REVIEW OF VACCINES (2008)
Successful expression and purification of human CIAPIN1 in baculovirus-insect cell system and application of this system to investigation of its potential methyltransferase activity
Zhiming Hao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2008)
Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK 293 cells in a hollow fiber bioreactor system
B. A. Jardin et al.
JOURNAL OF BIOTECHNOLOGY (2008)
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: Results of a phase I-II randomized clinical trial
Wendy A. Keitel et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Pathogenicity and Vaccine Efficacy of Different Clades of Asian H5N1 Avian Influenza A Viruses in Domestic Ducks
Jeong-Ki Kim et al.
JOURNAL OF VIROLOGY (2008)
Human infection with highly pathogenic H5N1 influenza virus
Andrea Gambotto et al.
LANCET (2008)
Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
Isabel Leroux-Roels et al.
PLOS ONE (2008)
Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle
Rick A. Bright et al.
PLOS ONE (2008)
Expression of Foot-and-Mouth Disease Virus Capsid Proteins in Silkworm-Baculovirus Expression System and Its Utilization as a Subunit Vaccine
Zhiyong Li et al.
PLOS ONE (2008)
Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs
Langzhou Song et al.
PLOS ONE (2008)
A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses
Ming-Wei Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Baculovirus expression and bioactivity of a soluble 140 kDa extracellular cleavage fragment of L1 neural cell adhesion molecule
Rebecca C. Cribb et al.
PROTEIN EXPRESSION AND PURIFICATION (2008)
Cross-Glade protective immunity of H5N1 influenza vaccines in a mouse model
Shin Murakami et al.
VACCINE (2008)
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
Terry M. Nolan et al.
VACCINE (2008)
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (HSN1) vaccine in infants and children
Terry Nolan et al.
VACCINE (2008)
A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets
Tomy Joseph et al.
VIROLOGY (2008)
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant
Mookkan Prabakaran et al.
VIROLOGY (2008)
Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza a viruses
Li-Mei Chen et al.
PLOS PATHOGENS (2008)
Display of heterologous proteins on gp64null baculovirus virions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct
Jian Zhou et al.
JOURNAL OF VIROLOGY (2008)
The threat of avian influenza A (H5N1). Part IV: development of vaccines
Jindrich Cinatl et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2007)
Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses
Huoying Shi et al.
VACCINE (2007)
Baculovirus expression vectors for insect and mammalian cells
J. Patrick Condreay et al.
CURRENT DRUG TARGETS (2007)
Influenza vaccine: The challenge of antigenic drift
F. Carrat et al.
VACCINE (2007)
Efficient gene delivery into mammalian cells mediated by a recombinant baculovirus containing a whispovirus ie1 promoter, a novel shuttle promoter between insect cells and mammalian cells
Hui Gao et al.
JOURNAL OF BIOTECHNOLOGY (2007)
Baculovirus-expressed influenza vaccine: a novel technology for safe and expeditious vaccine production for human use
Amar Safdar et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
被撤回的出版物: Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity (Retracted article. See vol. 388, pg. 620, 2009)
Liqun Lu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin
Rick A. Bright et al.
VACCINE (2007)
Avian influenza virus hemagglutinin display on baculovirus envelope: Cytoplasmic domain affects virus properties and vaccine potential
Ding-Gang Yang et al.
MOLECULAR THERAPY (2007)
A chimeric baculovirus displaying bovine herpesvirus-1 (BHV-1) glycoprotein D on its surface and their immunological properties
A. Peralta et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
A surface-modified baculovirus vector with improved gene delivery to B-lymphocytic cells
Jing Ge et al.
JOURNAL OF BIOTECHNOLOGY (2007)
Changing perspective on immunization against influenza
Bert E. Johansson et al.
VACCINE (2007)
Avian influenza virus (H5N1): a threat to human health
J. S. Malik Peiris et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets
Amorsolo L. Suguitan et al.
PLOS MEDICINE (2006)
RGD motifs on the surface of baculovirus enhance transduction of human lung carcinoma cells
Heli Matilainen et al.
JOURNAL OF BIOTECHNOLOGY (2006)
Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate
Sarah Bonnet et al.
VACCINE (2006)
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial
Jean-Louis Bresson et al.
LANCET (2006)
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults
JJ Treanor et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Expression and purification of an influenza hemagglutinin - one step closer to a recombinant protein-based influenza vaccine
K Wang et al.
VACCINE (2006)
Expression of hemagglutinin protein from the avian influenza virus H5N1 in a baculovirus/insect cell system significantly enhanced by suspension culture
N Nwe et al.
BMC MICROBIOLOGY (2006)
Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice
MA Hoelscher et al.
LANCET (2006)
Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo
MU Kaikkonen et al.
GENE THERAPY (2006)
Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine
YZ Ghendon et al.
VACCINE (2005)
A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin
J Stech et al.
NATURE MEDICINE (2005)
Baculovirus as versatile vectors for protein expression in insect and mammalian cells
TA Kost et al.
NATURE BIOTECHNOLOGY (2005)
Microarray and RT-PCR screening for white spot syndrome virus immediate-early genes in cycloheximide-treated shrimp
WJ Liu et al.
VIROLOGY (2005)
Baculovirus as a highly efficient expression vector in insect and mammalian cells
YC Hu
ACTA PHARMACOLOGICA SINICA (2005)
Live cold-adapted influenza A vaccine produced in Vero cell line
J Romanova et al.
VIRUS RESEARCH (2004)
High efficiency gene transfer into mammalian kidney cells using baculovirus vectors
CY Liang et al.
ARCHIVES OF VIROLOGY (2004)
Amino-terminal anchored surface display in insect cells and budded baculovirus using the amino-terminal end of neuraminidase
J Borg et al.
JOURNAL OF BIOTECHNOLOGY (2004)
Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate
H Chen et al.
VACCINE (2003)
Impact of glycosylation on the immunogenicity of a DNA-based influenza H5HA vaccine
RA Bright et al.
VIROLOGY (2003)
Pandemic preparedness:: lessons learnt from H2N2 and H9N2 candidate vaccines
N Hehme et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2002)
Recombinant baculoviruses as mammalian cell gene-delivery vectors
TA Kost et al.
TRENDS IN BIOTECHNOLOGY (2002)
Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins
T Latham et al.
JOURNAL OF VIROLOGY (2001)
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
KG Nicholson et al.
LANCET (2001)
In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors
L Pieroni et al.
HUMAN GENE THERAPY (2001)
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
JJ Treanor et al.
VACCINE (2001)
Baculovirus infection of nondividing mammalian cells: Mechanisms of entry and nuclear transport of capsids
ND van Loo et al.
JOURNAL OF VIROLOGY (2001)
Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector
C Sarkis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Expanding baculovirus surface display -: Modification of the native coat protein gp64 of Autographa californica NPV
WJ Ernst et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines
S Kodihalli et al.
VACCINE (2000)
Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years
DE Swayne et al.
VETERINARY MICROBIOLOGY (2000)
Share Paper
